ZNF443 is a zinc finger transcription factor localized to the nucleus that likely participates in RNA polymerase II-mediated transcriptional regulation. As a sequence-specific DNA-binding protein, it functions as a transcriptional regulator with potential involvement in apoptotic processes based on Gene Ontology annotations. Regarding disease relevance, ZNF443 expression is dysregulated in cancer contexts. In Wilms tumor (SK-NEP-1 cells), ZNF443 was significantly down-regulated following YM155 treatment, a survivin inhibitor that induces apoptosis and suppresses tumor growth 1. Similarly, ZNF443 was identified among dysregulated genes associated with radiotherapy response in nasopharyngeal carcinoma and head and neck squamous cell carcinoma, with altered ZNF443 expression linked to patient survival outcomes 2. Additionally, ZNF443 expression changes were observed during apoptosis induced by Paeoniae Radix in hepatoma cells 3. Clinical significance is suggested by ZNF443's association with cancer prognosis and treatment response. Its dysregulation appears linked to apoptotic pathways in multiple tumor types, potentially making it a biomarker for therapeutic response or prognostic indicator in cancer patients. However, the specific molecular mechanisms by which ZNF443 regulates transcription or contributes to apoptosis remain incompletely characterized in the provided literature.